Elevance Health Stock Probability Of Bankruptcy

ELV Stock

USD 389.25 2.35 0.60%

Elevance Health's odds of distress is less than 5% at this time. It is unlikely to undergo any financial trouble in the next 24 months. Elevance Health's Odds of financial turmoil is determined by interpolating and adjusting Elevance Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Elevance balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Elevance Health Piotroski F Score and Elevance Health Altman Z Score analysis.

For more information on how to buy Elevance Stock please use our How to Invest in Elevance Health guide.

Market Cap is likely to climb to about 90.2 B in 2025. Enterprise Value is likely to climb to about 112.2 B in 2025

Elevance Health Company odds of financial turmoil Analysis

Elevance Health's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Elevance Health Probability Of Bankruptcy

Less than 5%

Most of Elevance Health's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elevance Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Elevance Health probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Elevance Health odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Elevance Health financial health.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevance Health. If investors know Elevance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevance Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.50)

Dividend Share

6.52

Earnings Share

25.69

Revenue Per Share

759.167

Quarterly Revenue Growth

0.066

The market value of Elevance Health is measured differently than its book value, which is the value of Elevance that is recorded on the company's balance sheet. Investors also form their own opinion of Elevance Health's value that differs from its market value or its book value, called intrinsic value, which is Elevance Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevance Health's market value can be influenced by many factors that don't directly affect Elevance Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Elevance Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevance Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevance Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Elevance Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Elevance Health is extremely important. It helps to project a fair market value of Elevance Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Elevance Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Elevance Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Elevance Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Intangible Assets	Property Plant Equipment	Net Receivables	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Good Will	Deferred Long Term Liab	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Capital Stock
Total Assets		0.99	0.81	0.85	0.8	0.63	0.83	0.78	0.38	0.8	0.82	0.62	-0.39	0.23	0.77	0.98	0.38	0.27	0.96	-0.7	0.65	-0.02	0.75	0.75	-0.66
Total Stockholder Equity	0.99		0.82	0.84	0.79	0.63	0.82	0.78	0.37	0.78	0.82	0.6	-0.35	0.21	0.81	0.98	0.4	0.22	0.94	-0.69	0.59	-0.05	0.69	0.7	-0.6
Net Debt	0.81	0.82		0.95	0.91	0.85	0.98	0.9	0.68	0.89	0.75	0.36	-0.52	0.54	0.89	0.86	0.54	0.23	0.84	-0.88	0.73	0.1	0.56	0.68	-0.67
Total Liab	0.85	0.84	0.95		0.98	0.84	0.99	0.98	0.72	0.97	0.68	0.39	-0.63	0.59	0.87	0.86	0.38	0.38	0.9	-0.84	0.86	0.0	0.74	0.82	-0.81
Retained Earnings	0.8	0.79	0.91	0.98		0.85	0.97	0.97	0.76	0.99	0.66	0.32	-0.68	0.65	0.8	0.8	0.27	0.5	0.89	-0.8	0.89	-0.04	0.77	0.87	-0.84
Accounts Payable	0.63	0.63	0.85	0.84	0.85		0.86	0.86	0.78	0.83	0.55	0.12	-0.76	0.7	0.76	0.67	0.39	0.39	0.7	-0.75	0.73	0.02	0.55	0.73	-0.65
Long Term Debt	0.83	0.82	0.98	0.99	0.97	0.86		0.95	0.72	0.95	0.71	0.37	-0.59	0.59	0.88	0.86	0.46	0.35	0.88	-0.87	0.8	0.05	0.67	0.77	-0.75
Short Term Investments	0.78	0.78	0.9	0.98	0.97	0.86	0.95		0.8	0.96	0.58	0.23	-0.72	0.69	0.87	0.79	0.32	0.37	0.85	-0.77	0.88	-0.04	0.75	0.85	-0.83
Intangible Assets	0.38	0.37	0.68	0.72	0.76	0.78	0.72	0.8		0.74	0.33	-0.35	-0.75	0.98	0.63	0.43	0.19	0.31	0.53	-0.6	0.73	-0.02	0.55	0.71	-0.66
Property Plant Equipment	0.8	0.78	0.89	0.97	0.99	0.83	0.95	0.96	0.74		0.62	0.35	-0.65	0.63	0.77	0.79	0.26	0.55	0.89	-0.75	0.9	-0.04	0.8	0.88	-0.85
Net Receivables	0.82	0.82	0.75	0.68	0.66	0.55	0.71	0.58	0.33	0.62		0.48	-0.28	0.2	0.66	0.85	0.38	0.17	0.77	-0.76	0.43	0.12	0.5	0.53	-0.42
Total Current Assets	0.62	0.6	0.36	0.39	0.32	0.12	0.37	0.23	-0.35	0.35	0.48		0.09	-0.48	0.28	0.56	0.32	0.2	0.49	-0.29	0.21	0.01	0.31	0.21	-0.25
Short Term Debt	-0.39	-0.35	-0.52	-0.63	-0.68	-0.76	-0.59	-0.72	-0.75	-0.65	-0.28	0.09		-0.74	-0.48	-0.36	-0.03	-0.39	-0.5	0.4	-0.75	0.03	-0.69	-0.76	0.7
Common Stock	0.23	0.21	0.54	0.59	0.65	0.7	0.59	0.69	0.98	0.63	0.2	-0.48	-0.74		0.47	0.27	0.08	0.34	0.41	-0.48	0.67	-0.03	0.5	0.66	-0.6
Current Deferred Revenue	0.77	0.81	0.89	0.87	0.8	0.76	0.88	0.87	0.63	0.77	0.66	0.28	-0.48	0.47		0.82	0.53	-0.01	0.75	-0.84	0.57	0.14	0.49	0.56	-0.51
Good Will	0.98	0.98	0.86	0.86	0.8	0.67	0.86	0.79	0.43	0.79	0.85	0.56	-0.36	0.27	0.82		0.47	0.19	0.94	-0.75	0.61	0.02	0.68	0.71	-0.61
Deferred Long Term Liab	0.38	0.4	0.54	0.38	0.27	0.39	0.46	0.32	0.19	0.26	0.38	0.32	-0.03	0.08	0.53	0.47		-0.15	0.23	-0.41	0.11	0.13	0.02	0.08	-0.1
Net Tangible Assets	0.27	0.22	0.23	0.38	0.5	0.39	0.35	0.37	0.31	0.55	0.17	0.2	-0.39	0.34	-0.01	0.19	-0.15		0.39	-0.13	0.54	-0.33	0.59	0.61	-0.52
Long Term Debt Total	0.96	0.94	0.84	0.9	0.89	0.7	0.88	0.85	0.53	0.89	0.77	0.49	-0.5	0.41	0.75	0.94	0.23	0.39		-0.73	0.77	-0.01	0.82	0.86	-0.78
Capital Surpluse	-0.7	-0.69	-0.88	-0.84	-0.8	-0.75	-0.87	-0.77	-0.6	-0.75	-0.76	-0.29	0.4	-0.48	-0.84	-0.75	-0.41	-0.13	-0.73		-0.56	-0.34	-0.42	-0.52	0.5
Long Term Investments	0.65	0.59	0.73	0.86	0.89	0.73	0.8	0.88	0.73	0.9	0.43	0.21	-0.75	0.67	0.57	0.61	0.11	0.54	0.77	-0.56		-0.08	0.8	0.92	-0.99
Short Long Term Debt	-0.02	-0.05	0.1	0.0	-0.04	0.02	0.05	-0.04	-0.02	-0.04	0.12	0.01	0.03	-0.03	0.14	0.02	0.13	-0.33	-0.01	-0.34	-0.08		-0.12	-0.11	0.09
Cash And Equivalents	0.75	0.69	0.56	0.74	0.77	0.55	0.67	0.75	0.55	0.8	0.5	0.31	-0.69	0.5	0.49	0.68	0.02	0.59	0.82	-0.42	0.8	-0.12		0.94	-0.82
Net Invested Capital	0.75	0.7	0.68	0.82	0.87	0.73	0.77	0.85	0.71	0.88	0.53	0.21	-0.76	0.66	0.56	0.71	0.08	0.61	0.86	-0.52	0.92	-0.11	0.94		-0.93
Capital Stock	-0.66	-0.6	-0.67	-0.81	-0.84	-0.65	-0.75	-0.83	-0.66	-0.85	-0.42	-0.25	0.7	-0.6	-0.51	-0.61	-0.1	-0.52	-0.78	0.5	-0.99	0.09	-0.82	-0.93

Click cells to compare fundamentals

The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Competition

Predict Elevance Health

Based on the latest financial disclosure, Elevance Health has a Probability Of Bankruptcy of 5.0%. This is 88.45% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 87.45% higher than that of the company.

Elevance Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevance Health's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elevance Health could also be used in its relative valuation, which is a method of valuing Elevance Health by comparing valuation metrics of similar companies.

Elevance Health is currently under evaluation in probability of bankruptcy category among its peers.

Elevance Health Main Bankruptcy Drivers

	2020	2021	2022	2023	2024	2025 (projected)
Return On Assets	0.0528	0.0627	0.0574	0.055	0.0512	0.04
Asset Turnover	1.35	1.41	1.42	1.52	1.57	1.55
Net Debt	14.3B	18.2B	16.7B	18.6B	20.9B	22.0B
Total Current Liabilities	18.8B	21.5B	39.7B	26.3B	30.2B	31.8B
Non Current Liabilities Total	21.4B	23.8B	26.7B	43.2B	75.2B	79.0B
Total Assets	86.6B	97.3B	102.8B	108.9B	116.7B	60.5B
Total Current Assets	40.1B	44.6B	55.6B	60.0B	8.3B	7.9B
Total Cash From Operating Activities	10.7B	8.4B	8.4B	8.1B	5.8B	4.3B

Elevance Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Elevance Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Elevance Health's managers, analysts, and investors.

Environmental

Governance

Social

Elevance Fundamentals

	Return On Equity	0.15
	Return On Asset	0.0558
	Profit Margin	0.03 %
	Operating Margin	0.02 %
	Current Valuation	113.22 B
	Shares Outstanding	231.92 M
	Shares Owned By Insiders	0.30 %
	Shares Owned By Institutions	91.58 %
	Number Of Shares Shorted	2.81 M
	Price To Earning	19.27 X
	Price To Book	2.19 X
	Price To Sales	0.51 X
	Revenue	177.01 B
	Gross Profit	49.24 B
	EBITDA	137.24 B
	Net Income	5.97 B
	Cash And Equivalents	7.39 B
	Cash Per Share	150.32 X
	Total Debt	29.22 B
	Debt To Equity	0.66 %
	Current Ratio	1.35 X
	Book Value Per Share	178.78 X
	Cash Flow From Operations	5.81 B
	Short Ratio	1.58 X
	Earnings Per Share	25.69 X
	Price To Earnings To Growth	0.85 X
	Target Price	494.29
	Beta	0.84
	Market Capitalization	90.28 B
	Total Asset	116.67 B
	Retained Earnings	31.75 B
	Annual Yield	0.02 %
	Five Year Return	1.13 %
	Net Asset	116.67 B
	Last Dividend Paid	6.52

About Elevance Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Elevance Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevance Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevance Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elevance Stock Analysis

When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Elevance Health Stock Probability Of Bankruptcy

Elevance Health Company odds of financial turmoil Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Elevance Health Probability Of Bankruptcy

Elevance Probability Of Bankruptcy Driver Correlations

Elevance Probability Of Bankruptcy Peer Comparison

Elevance Health Main Bankruptcy Drivers

Elevance Health ESG Sustainability

Elevance Fundamentals

About Elevance Health Fundamental Analysis

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Elevance Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY